sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Angiogenesis Modulators Market Insights and Forecast to 2026

Global Angiogenesis Modulators Market Insights and Forecast to 2026

Category : Pharmaceuticals and Healthcare QY Research Pages :117
Published Date : 2020-12-02

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Angiogenesis Modulators Market with our analysts monitoring the situation across the globe.
Angiogenesis Modulators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angiogenesis Modulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Angiogenesis Modulators market is segmented into Angiogenesis Inhibitors Angiogenesis Stimulators Angiogenin Others Segment by Application, the Angiogenesis Modulators market is segmented into Breast Cancer Colorectal Cancer Lung Cancer Prostate Cancer Others Regional and Country-level Analysis The Angiogenesis Modulators market is analysed and market size information is provided by regions (countries). The key regions covered in the Angiogenesis Modulators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Angiogenesis Modulators Market Share Analysis Angiogenesis Modulators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiogenesis Modulators business, the date to enter into the Angiogenesis Modulators market, Angiogenesis Modulators product introduction, recent developments, etc. The major vendors covered: Celgene Corporation (USA) Eisai (Japan) Amgen, Inc. (USA) Genentech, Inc. (USA) GlaxoSmithKline plc (UK) Bayer Pharma AG (Germany) Bionomics Ltd. (Australia) CASI Pharmaceuticals, Inc. (USA) AstraZeneca plc (UK) Eli Lilly and Company (USA) F.Hoffmann-La Roche AG (Switzerland)
1 Study Coverage 1.1 Angiogenesis Modulators Product Introduction 1.2 Market Segments 1.3 Key Angiogenesis Modulators Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Angiogenesis Modulators Market Size Growth Rate by Type 1.4.2 Angiogenesis Inhibitors 1.4.3 Angiogenesis Stimulators 1.4.4 Angiogenin 1.4.5 Others 1.5 Market by Application 1.5.1 Global Angiogenesis Modulators Market Size Growth Rate by Application 1.5.2 Breast Cancer 1.5.3 Colorectal Cancer 1.5.4 Lung Cancer 1.5.5 Prostate Cancer 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Angiogenesis Modulators Market Size, Estimates and Forecasts 2.1.1 Global Angiogenesis Modulators Revenue 2015-2026 2.1.2 Global Angiogenesis Modulators Sales 2015-2026 2.2 Global Angiogenesis Modulators, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Angiogenesis Modulators Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Angiogenesis Modulators Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Angiogenesis Modulators Competitor Landscape by Players 3.1 Angiogenesis Modulators Sales by Manufacturers 3.1.1 Angiogenesis Modulators Sales by Manufacturers (2015-2020) 3.1.2 Angiogenesis Modulators Sales Market Share by Manufacturers (2015-2020) 3.2 Angiogenesis Modulators Revenue by Manufacturers 3.2.1 Angiogenesis Modulators Revenue by Manufacturers (2015-2020) 3.2.2 Angiogenesis Modulators Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Angiogenesis Modulators Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Angiogenesis Modulators Revenue in 2019 3.2.5 Global Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Angiogenesis Modulators Price by Manufacturers 3.4 Angiogenesis Modulators Manufacturing Base Distribution, Product Types 3.4.1 Angiogenesis Modulators Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Angiogenesis Modulators Product Type 3.4.3 Date of International Manufacturers Enter into Angiogenesis Modulators Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Angiogenesis Modulators Market Size by Type (2015-2020) 4.1.1 Global Angiogenesis Modulators Sales by Type (2015-2020) 4.1.2 Global Angiogenesis Modulators Revenue by Type (2015-2020) 4.1.3 Angiogenesis Modulators Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Angiogenesis Modulators Market Size Forecast by Type (2021-2026) 4.2.1 Global Angiogenesis Modulators Sales Forecast by Type (2021-2026) 4.2.2 Global Angiogenesis Modulators Revenue Forecast by Type (2021-2026) 4.2.3 Angiogenesis Modulators Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Angiogenesis Modulators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Angiogenesis Modulators Market Size by Application (2015-2020) 5.1.1 Global Angiogenesis Modulators Sales by Application (2015-2020) 5.1.2 Global Angiogenesis Modulators Revenue by Application (2015-2020) 5.1.3 Angiogenesis Modulators Price by Application (2015-2020) 5.2 Angiogenesis Modulators Market Size Forecast by Application (2021-2026) 5.2.1 Global Angiogenesis Modulators Sales Forecast by Application (2021-2026) 5.2.2 Global Angiogenesis Modulators Revenue Forecast by Application (2021-2026) 5.2.3 Global Angiogenesis Modulators Price Forecast by Application (2021-2026) 6 North America 6.1 North America Angiogenesis Modulators by Country 6.1.1 North America Angiogenesis Modulators Sales by Country 6.1.2 North America Angiogenesis Modulators Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Angiogenesis Modulators Market Facts & Figures by Type 6.3 North America Angiogenesis Modulators Market Facts & Figures by Application 7 Europe 7.1 Europe Angiogenesis Modulators by Country 7.1.1 Europe Angiogenesis Modulators Sales by Country 7.1.2 Europe Angiogenesis Modulators Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Angiogenesis Modulators Market Facts & Figures by Type 7.3 Europe Angiogenesis Modulators Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Angiogenesis Modulators by Region 8.1.1 Asia Pacific Angiogenesis Modulators Sales by Region 8.1.2 Asia Pacific Angiogenesis Modulators Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Angiogenesis Modulators Market Facts & Figures by Type 8.3 Asia Pacific Angiogenesis Modulators Market Facts & Figures by Application 9 Latin America 9.1 Latin America Angiogenesis Modulators by Country 9.1.1 Latin America Angiogenesis Modulators Sales by Country 9.1.2 Latin America Angiogenesis Modulators Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Angiogenesis Modulators Market Facts & Figures by Type 9.3 Central & South America Angiogenesis Modulators Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Angiogenesis Modulators by Country 10.1.1 Middle East and Africa Angiogenesis Modulators Sales by Country 10.1.2 Middle East and Africa Angiogenesis Modulators Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Angiogenesis Modulators Market Facts & Figures by Type 10.3 Middle East and Africa Angiogenesis Modulators Market Facts & Figures by Application 11 Company Profiles 11.1 Celgene Corporation (USA) 11.1.1 Celgene Corporation (USA) Corporation Information 11.1.2 Celgene Corporation (USA) Description and Business Overview 11.1.3 Celgene Corporation (USA) Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Celgene Corporation (USA) Angiogenesis Modulators Products Offered 11.1.5 Celgene Corporation (USA) Related Developments 11.2 Eisai (Japan) 11.2.1 Eisai (Japan) Corporation Information 11.2.2 Eisai (Japan) Description and Business Overview 11.2.3 Eisai (Japan) Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Eisai (Japan) Angiogenesis Modulators Products Offered 11.2.5 Eisai (Japan) Related Developments 11.3 Amgen, Inc. (USA) 11.3.1 Amgen, Inc. (USA) Corporation Information 11.3.2 Amgen, Inc. (USA) Description and Business Overview 11.3.3 Amgen, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Products Offered 11.3.5 Amgen, Inc. (USA) Related Developments 11.4 Genentech, Inc. (USA) 11.4.1 Genentech, Inc. (USA) Corporation Information 11.4.2 Genentech, Inc. (USA) Description and Business Overview 11.4.3 Genentech, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Products Offered 11.4.5 Genentech, Inc. (USA) Related Developments 11.5 GlaxoSmithKline plc (UK) 11.5.1 GlaxoSmithKline plc (UK) Corporation Information 11.5.2 GlaxoSmithKline plc (UK) Description and Business Overview 11.5.3 GlaxoSmithKline plc (UK) Sales, Revenue and Gross Margin (2015-2020) 11.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Products Offered 11.5.5 GlaxoSmithKline plc (UK) Related Developments 11.6 Bayer Pharma AG (Germany) 11.6.1 Bayer Pharma AG (Germany) Corporation Information 11.6.2 Bayer Pharma AG (Germany) Description and Business Overview 11.6.3 Bayer Pharma AG (Germany) Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Products Offered 11.6.5 Bayer Pharma AG (Germany) Related Developments 11.7 Bionomics Ltd. (Australia) 11.7.1 Bionomics Ltd. (Australia) Corporation Information 11.7.2 Bionomics Ltd. (Australia) Description and Business Overview 11.7.3 Bionomics Ltd. (Australia) Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Products Offered 11.7.5 Bionomics Ltd. (Australia) Related Developments 11.8 CASI Pharmaceuticals, Inc. (USA) 11.8.1 CASI Pharmaceuticals, Inc. (USA) Corporation Information 11.8.2 CASI Pharmaceuticals, Inc. (USA) Description and Business Overview 11.8.3 CASI Pharmaceuticals, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020) 11.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Products Offered 11.8.5 CASI Pharmaceuticals, Inc. (USA) Related Developments 11.9 AstraZeneca plc (UK) 11.9.1 AstraZeneca plc (UK) Corporation Information 11.9.2 AstraZeneca plc (UK) Description and Business Overview 11.9.3 AstraZeneca plc (UK) Sales, Revenue and Gross Margin (2015-2020) 11.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Products Offered 11.9.5 AstraZeneca plc (UK) Related Developments 11.10 Eli Lilly and Company (USA) 11.10.1 Eli Lilly and Company (USA) Corporation Information 11.10.2 Eli Lilly and Company (USA) Description and Business Overview 11.10.3 Eli Lilly and Company (USA) Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Products Offered 11.10.5 Eli Lilly and Company (USA) Related Developments 11.1 Celgene Corporation (USA) 11.1.1 Celgene Corporation (USA) Corporation Information 11.1.2 Celgene Corporation (USA) Description and Business Overview 11.1.3 Celgene Corporation (USA) Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Celgene Corporation (USA) Angiogenesis Modulators Products Offered 11.1.5 Celgene Corporation (USA) Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Angiogenesis Modulators Market Estimates and Projections by Region 12.1.1 Global Angiogenesis Modulators Sales Forecast by Regions 2021-2026 12.1.2 Global Angiogenesis Modulators Revenue Forecast by Regions 2021-2026 12.2 North America Angiogenesis Modulators Market Size Forecast (2021-2026) 12.2.1 North America: Angiogenesis Modulators Sales Forecast (2021-2026) 12.2.2 North America: Angiogenesis Modulators Revenue Forecast (2021-2026) 12.2.3 North America: Angiogenesis Modulators Market Size Forecast by Country (2021-2026) 12.3 Europe Angiogenesis Modulators Market Size Forecast (2021-2026) 12.3.1 Europe: Angiogenesis Modulators Sales Forecast (2021-2026) 12.3.2 Europe: Angiogenesis Modulators Revenue Forecast (2021-2026) 12.3.3 Europe: Angiogenesis Modulators Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Angiogenesis Modulators Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Angiogenesis Modulators Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Angiogenesis Modulators Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Angiogenesis Modulators Market Size Forecast by Region (2021-2026) 12.5 Latin America Angiogenesis Modulators Market Size Forecast (2021-2026) 12.5.1 Latin America: Angiogenesis Modulators Sales Forecast (2021-2026) 12.5.2 Latin America: Angiogenesis Modulators Revenue Forecast (2021-2026) 12.5.3 Latin America: Angiogenesis Modulators Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Angiogenesis Modulators Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Angiogenesis Modulators Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Angiogenesis Modulators Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Angiogenesis Modulators Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Angiogenesis Modulators Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Angiogenesis Modulators Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Angiogenesis Modulators Market Segments Table 2. Ranking of Global Top Angiogenesis Modulators Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Angiogenesis Modulators Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million) Table 4. Major Manufacturers of Angiogenesis Inhibitors Table 5. Major Manufacturers of Angiogenesis Stimulators Table 6. Major Manufacturers of Angiogenin Table 7. Major Manufacturers of Others Table 8. Global Angiogenesis Modulators Market Size Growth Rate by Application 2020-2026 (K MT) Table 9. Global Angiogenesis Modulators Market Size by Region (K MT) & (US$ Million): 2020 VS 2026 Table 10. Global Angiogenesis Modulators Sales by Regions 2015-2020 (K MT) Table 11. Global Angiogenesis Modulators Sales Market Share by Regions (2015-2020) Table 12. Global Angiogenesis Modulators Revenue by Regions 2015-2020 (US$ Million) Table 13. Global Angiogenesis Modulators Sales by Manufacturers (2015-2020) (K MT) Table 14. Global Angiogenesis Modulators Sales Share by Manufacturers (2015-2020) Table 15. Global Angiogenesis Modulators Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global Angiogenesis Modulators by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiogenesis Modulators as of 2019) Table 17. Angiogenesis Modulators Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. Angiogenesis Modulators Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers Angiogenesis Modulators Price (2015-2020) (USD/MT) Table 20. Angiogenesis Modulators Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Angiogenesis Modulators Product Type Table 22. Date of International Manufacturers Enter into Angiogenesis Modulators Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Angiogenesis Modulators Sales by Type (2015-2020) (K MT) Table 25. Global Angiogenesis Modulators Sales Share by Type (2015-2020) Table 26. Global Angiogenesis Modulators Revenue by Type (2015-2020) (US$ Million) Table 27. Global Angiogenesis Modulators Revenue Share by Type (2015-2020) Table 28. Angiogenesis Modulators Average Selling Price (ASP) by Type 2015-2020 (USD/MT) Table 29. Global Angiogenesis Modulators Sales by Application (2015-2020) (K MT) Table 30. Global Angiogenesis Modulators Sales Share by Application (2015-2020) Table 31. North America Angiogenesis Modulators Sales by Country (2015-2020) (K MT) Table 32. North America Angiogenesis Modulators Sales Market Share by Country (2015-2020) Table 33. North America Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million) Table 34. North America Angiogenesis Modulators Revenue Market Share by Country (2015-2020) Table 35. North America Angiogenesis Modulators Sales by Type (2015-2020) (K MT) Table 36. North America Angiogenesis Modulators Sales Market Share by Type (2015-2020) Table 37. North America Angiogenesis Modulators Sales by Application (2015-2020) (K MT) Table 38. North America Angiogenesis Modulators Sales Market Share by Application (2015-2020) Table 39. Europe Angiogenesis Modulators Sales by Country (2015-2020) (K MT) Table 40. Europe Angiogenesis Modulators Sales Market Share by Country (2015-2020) Table 41. Europe Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million) Table 42. Europe Angiogenesis Modulators Revenue Market Share by Country (2015-2020) Table 43. Europe Angiogenesis Modulators Sales by Type (2015-2020) (K MT) Table 44. Europe Angiogenesis Modulators Sales Market Share by Type (2015-2020) Table 45. Europe Angiogenesis Modulators Sales by Application (2015-2020) (K MT) Table 46. Europe Angiogenesis Modulators Sales Market Share by Application (2015-2020) Table 47. Asia Pacific Angiogenesis Modulators Sales by Region (2015-2020) (K MT) Table 48. Asia Pacific Angiogenesis Modulators Sales Market Share by Region (2015-2020) Table 49. Asia Pacific Angiogenesis Modulators Revenue by Region (2015-2020) (US$ Million) Table 50. Asia Pacific Angiogenesis Modulators Revenue Market Share by Region (2015-2020) Table 51. Asia Pacific Angiogenesis Modulators Sales by Type (2015-2020) (K MT) Table 52. Asia Pacific Angiogenesis Modulators Sales Market Share by Type (2015-2020) Table 53. Asia Pacific Angiogenesis Modulators Sales by Application (2015-2020) (K MT) Table 54. Asia Pacific Angiogenesis Modulators Sales Market Share by Application (2015-2020) Table 55. Latin America Angiogenesis Modulators Sales by Country (2015-2020) (K MT) Table 56. Latin America Angiogenesis Modulators Sales Market Share by Country (2015-2020) Table 57. Latin Americaa Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million) Table 58. Latin America Angiogenesis Modulators Revenue Market Share by Country (2015-2020) Table 59. Latin America Angiogenesis Modulators Sales by Type (2015-2020) (K MT) Table 60. Latin America Angiogenesis Modulators Sales Market Share by Type (2015-2020) Table 61. Latin America Angiogenesis Modulators Sales by Application (2015-2020) (K MT) Table 62. Latin America Angiogenesis Modulators Sales Market Share by Application (2015-2020) Table 63. Middle East and Africa Angiogenesis Modulators Sales by Country (2015-2020) (K MT) Table 64. Middle East and Africa Angiogenesis Modulators Sales Market Share by Country (2015-2020) Table 65. Middle East and Africa Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million) Table 66. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Country (2015-2020) Table 67. Middle East and Africa Angiogenesis Modulators Sales by Type (2015-2020) (K MT) Table 68. Middle East and Africa Angiogenesis Modulators Sales Market Share by Type (2015-2020) Table 69. Middle East and Africa Angiogenesis Modulators Sales by Application (2015-2020) (K MT) Table 70. Middle East and Africa Angiogenesis Modulators Sales Market Share by Application (2015-2020) Table 71. Celgene Corporation (USA) Corporation Information Table 72. Celgene Corporation (USA) Description and Major Businesses Table 73. Celgene Corporation (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 74. Celgene Corporation (USA) Product Table 75. Celgene Corporation (USA) Recent Development Table 76. Eisai (Japan) Corporation Information Table 77. Eisai (Japan) Description and Major Businesses Table 78. Eisai (Japan) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 79. Eisai (Japan) Product Table 80. Eisai (Japan) Recent Development Table 81. Amgen, Inc. (USA) Corporation Information Table 82. Amgen, Inc. (USA) Description and Major Businesses Table 83. Amgen, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 84. Amgen, Inc. (USA) Product Table 85. Amgen, Inc. (USA) Recent Development Table 86. Genentech, Inc. (USA) Corporation Information Table 87. Genentech, Inc. (USA) Description and Major Businesses Table 88. Genentech, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 89. Genentech, Inc. (USA) Product Table 90. Genentech, Inc. (USA) Recent Development Table 91. GlaxoSmithKline plc (UK) Corporation Information Table 92. GlaxoSmithKline plc (UK) Description and Major Businesses Table 93. GlaxoSmithKline plc (UK) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 94. GlaxoSmithKline plc (UK) Product Table 95. GlaxoSmithKline plc (UK) Recent Development Table 96. Bayer Pharma AG (Germany) Corporation Information Table 97. Bayer Pharma AG (Germany) Description and Major Businesses Table 98. Bayer Pharma AG (Germany) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 99. Bayer Pharma AG (Germany) Product Table 100. Bayer Pharma AG (Germany) Recent Development Table 101. Bionomics Ltd. (Australia) Corporation Information Table 102. Bionomics Ltd. (Australia) Description and Major Businesses Table 103. Bionomics Ltd. (Australia) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 104. Bionomics Ltd. (Australia) Product Table 105. Bionomics Ltd. (Australia) Recent Development Table 106. CASI Pharmaceuticals, Inc. (USA) Corporation Information Table 107. CASI Pharmaceuticals, Inc. (USA) Description and Major Businesses Table 108. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 109. CASI Pharmaceuticals, Inc. (USA) Product Table 110. CASI Pharmaceuticals, Inc. (USA) Recent Development Table 111. AstraZeneca plc (UK) Corporation Information Table 112. AstraZeneca plc (UK) Description and Major Businesses Table 113. AstraZeneca plc (UK) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 114. AstraZeneca plc (UK) Product Table 115. AstraZeneca plc (UK) Recent Development Table 116. Eli Lilly and Company (USA) Corporation Information Table 117. Eli Lilly and Company (USA) Description and Major Businesses Table 118. Eli Lilly and Company (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 119. Eli Lilly and Company (USA) Product Table 120. Eli Lilly and Company (USA) Recent Development Table 121. F.Hoffmann-La Roche AG (Switzerland) Corporation Information Table 122. F.Hoffmann-La Roche AG (Switzerland) Description and Major Businesses Table 123. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 124. F.Hoffmann-La Roche AG (Switzerland) Product Table 125. F.Hoffmann-La Roche AG (Switzerland) Recent Development Table 126. Global Angiogenesis Modulators Sales Forecast by Regions (2021-2026) (K MT) Table 127. Global Angiogenesis Modulators Sales Market Share Forecast by Regions (2021-2026) Table 128. Global Angiogenesis Modulators Revenue Forecast by Regions (2021-2026) (US$ Million) Table 129. Global Angiogenesis Modulators Revenue Market Share Forecast by Regions (2021-2026) Table 130. North America: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT) Table 131. North America: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million) Table 132. Europe: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT) Table 133. Europe: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million) Table 134. Asia Pacific: Angiogenesis Modulators Sales Forecast by Region (2021-2026) (K MT) Table 135. Asia Pacific: Angiogenesis Modulators Revenue Forecast by Region (2021-2026) (US$ Million) Table 136. Latin America: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT) Table 137. Latin America: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million) Table 138. Middle East and Africa: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT) Table 139. Middle East and Africa: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million) Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 141. Key Challenges Table 142. Market Risks Table 143. Main Points Interviewed from Key Angiogenesis Modulators Players Table 144. Angiogenesis Modulators Customers List Table 145. Angiogenesis Modulators Distributors List Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Angiogenesis Modulators Product Picture Figure 2. Global Angiogenesis Modulators Sales Market Share by Type in 2020 & 2026 Figure 3. Angiogenesis Inhibitors Product Picture Figure 4. Angiogenesis Stimulators Product Picture Figure 5. Angiogenin Product Picture Figure 6. Others Product Picture Figure 7. Global Angiogenesis Modulators Sales Market Share by Application in 2020 & 2026 Figure 8. Breast Cancer Figure 9. Colorectal Cancer Figure 10. Lung Cancer Figure 11. Prostate Cancer Figure 12. Others Figure 13. Angiogenesis Modulators Report Years Considered Figure 14. Global Angiogenesis Modulators Market Size 2015-2026 (US$ Million) Figure 15. Global Angiogenesis Modulators Sales 2015-2026 (K MT) Figure 16. Global Angiogenesis Modulators Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Global Angiogenesis Modulators Sales Market Share by Region (2015-2020) Figure 18. Global Angiogenesis Modulators Sales Market Share by Region in 2019 Figure 19. Global Angiogenesis Modulators Revenue Market Share by Region (2015-2020) Figure 20. Global Angiogenesis Modulators Revenue Market Share by Region in 2019 Figure 21. Global Angiogenesis Modulators Sales Share by Manufacturer in 2019 Figure 22. The Top 10 and 5 Players Market Share by Angiogenesis Modulators Revenue in 2019 Figure 23. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 24. Global Angiogenesis Modulators Sales Market Share by Type (2015-2020) Figure 25. Global Angiogenesis Modulators Sales Market Share by Type in 2019 Figure 26. Global Angiogenesis Modulators Revenue Market Share by Type (2015-2020) Figure 27. Global Angiogenesis Modulators Revenue Market Share by Type in 2019 Figure 28. Global Angiogenesis Modulators Market Share by Price Range (2015-2020) Figure 29. Global Angiogenesis Modulators Sales Market Share by Application (2015-2020) Figure 30. Global Angiogenesis Modulators Sales Market Share by Application in 2019 Figure 31. Global Angiogenesis Modulators Revenue Market Share by Application (2015-2020) Figure 32. Global Angiogenesis Modulators Revenue Market Share by Application in 2019 Figure 33. North America Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT) Figure 34. North America Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million) Figure 35. North America Angiogenesis Modulators Sales Market Share by Country in 2019 Figure 36. North America Angiogenesis Modulators Revenue Market Share by Country in 2019 Figure 37. U.S. Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 38. U.S. Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Canada Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 40. Canada Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. North America Angiogenesis Modulators Market Share by Type in 2019 Figure 42. North America Angiogenesis Modulators Market Share by Application in 2019 Figure 43. Europe Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT) Figure 44. Europe Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million) Figure 45. Europe Angiogenesis Modulators Sales Market Share by Country in 2019 Figure 46. Europe Angiogenesis Modulators Revenue Market Share by Country in 2019 Figure 47. Germany Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 48. Germany Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. France Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 50. France Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. U.K. Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 52. U.K. Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Italy Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 54. Italy Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Russia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 56. Russia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Europe Angiogenesis Modulators Market Share by Type in 2019 Figure 58. Europe Angiogenesis Modulators Market Share by Application in 2019 Figure 59. Asia Pacific Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT) Figure 60. Asia Pacific Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Angiogenesis Modulators Sales Market Share by Region in 2019 Figure 62. Asia Pacific Angiogenesis Modulators Revenue Market Share by Region in 2019 Figure 63. China Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 64. China Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 66. Japan Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 68. South Korea Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 70. India Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 72. Australia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 74. Taiwan Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 76. Indonesia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 78. Thailand Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 80. Malaysia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 82. Philippines Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 84. Vietnam Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Asia Pacific Angiogenesis Modulators Market Share by Type in 2019 Figure 86. Asia Pacific Angiogenesis Modulators Market Share by Application in 2019 Figure 87. Latin America Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT) Figure 88. Latin America Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million) Figure 89. Latin America Angiogenesis Modulators Sales Market Share by Country in 2019 Figure 90. Latin America Angiogenesis Modulators Revenue Market Share by Country in 2019 Figure 91. Mexico Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 92. Mexico Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Brazil Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 94. Brazil Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Argentina Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 96. Argentina Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Latin America Angiogenesis Modulators Market Share by Type in 2019 Figure 98. Latin America Angiogenesis Modulators Market Share by Application in 2019 Figure 99. Middle East and Africa Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT) Figure 100. Middle East and Africa Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million) Figure 101. Middle East and Africa Angiogenesis Modulators Sales Market Share by Country in 2019 Figure 102. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Country in 2019 Figure 103. Turkey Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 104. Turkey Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Saudi Arabia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 106. Saudi Arabia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. U.A.E Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT) Figure 108. U.A.E Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. Middle East and Africa Angiogenesis Modulators Market Share by Type in 2019 Figure 110. Middle East and Africa Angiogenesis Modulators Market Share by Application in 2019 Figure 111. North America Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT) Figure 112. North America Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Europe Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT) Figure 114. Europe Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Asia Pacific Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT) Figure 116. Asia Pacific Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Latin America Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT) Figure 118. Latin America Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Middle East and Africa Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT) Figure 120. Middle East and Africa Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 121. Porter's Five Forces Analysis Figure 122. Channels of Distribution Figure 123. Distributors Profiles Figure 124. Bottom-up and Top-down Approaches for This Report Figure 125. Data Triangulation Figure 126. Key Executives Interviewed

Get Free Sample

Related Reports

Global Angiogenesis Modulators Market Insights and Forecast to 2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Angiogenesis Modulators Market Insights and Forecast to 2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Angiogenesis Modulators Market Insights and Forecast to 2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Angiogenesis Modulators Market Insights and Forecast to 2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Angiogenesis Modulators Market Insights and Forecast to 2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)